Improvement of Insomnia Symptoms following a Single 4-Hour CBT-I Workshop.

Study Objectives: : Cognitive behavioral treatment for insomnia (CBT-I) is the first line of treatment for insomnia. However, the expanded use of CBT-I is limited by the number of specialty-trained clinicians in addition to the duration and cost of individual treatment sessions. One viable option is a single-session educational group format delivered by a trained health educator.

Insomnia and Anxiety: Diagnostic and Management Implications of Complex Interactions.

Concurrent clinical presentation of insomnia and anxiety is frequent in clinical practice. The onset and course of anxiety and insomnia are intimately related; traditional conceptualizations of insomnia as secondary to anxiety are no longer clinically viable. Evolving evidence suggests a relationship between these 2 conditions that is complex and reciprocal and that evolves over time.

Predictors and patterns of insomnia symptoms in OSA before and after PAP therapy.

Objective: Identify factors that predict improvement versus persistence of insomnia symptoms following treatment of obstructive sleep apnea (OSA) with positive airway pressure (PAP) therapy.

Methods: Archival data from 68 PAP-treated sleep apnea patients aged 25-83 were analyzed using nonparametric tests and stepwise regression to assess the relationships between insomnia symptoms, multiple OSA variables, and PAP use over time.

Results: Pretreatment insomnia symptom severity (ISS; b = -0.

Comorbid insomnia and sleep disordered breathing.

Sufficient evidence has accumulated to warrant conceptualization of comorbid insomnia and sleep disordered breathing (SDB) as a distinct clinical syndrome. As such, diagnostic and treatment approaches should be founded on an integrated and multidisciplinary approach with equivalent clinical attention and priority given to both insomnia and respiratory aspects of patients' presenting complaints. Several well established and effective treatments exist for both insomnia and SDB.

Is insomnia an independent predictor of obstructive sleep apnea?

Introduction: Obstructive sleep apnea (OSA) is a disorder with high prevalence in primary care. However, little research exists on screening for OSA in primary care samples.

Methods: One hundred family medicine patients completed standardized symptom and demographic questionnaires and a structured clinical interview for sleep disorders.

Acetazolamide as an adjunct to CPAP treatment: a case of complex sleep apnea in a patient on long-acting opioid therapy.

A 41-year-old white woman on long-acting opioid therapy was diagnosed with moderate obstructive sleep apnea. On initiation of continuous positive airway pressure (CPAP), she manifested severe central apnea that was unresponsive to supplemental oxygen and interfered with CPAP titration. Acetazolamide, 250 mg, nightly at bedtime was initiated, and CPAP titration was repeated.